Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Ardent Health Partners, Inc. (ARDT)ARDT

Upturn stock ratingUpturn stock rating
Ardent Health Partners, Inc.
$16.44
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/20/2024: ARDT (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: -10.95%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 9
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/20/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: -10.95%
Avg. Invested days: 9
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/20/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.59B USD
Price to earnings Ratio 30.76
1Y Target Price 22.78
Dividends yield (FY) -
Basic EPS (TTM) 0.59
Volume (30-day avg) 253137
Beta -
52 Weeks Range 14.57 - 20.72
Updated Date 11/17/2024
Company Size Mid-Cap Stock
Market Capitalization 2.59B USD
Price to earnings Ratio 30.76
1Y Target Price 22.78
Dividends yield (FY) -
Basic EPS (TTM) 0.59
Volume (30-day avg) 253137
Beta -
52 Weeks Range 14.57 - 20.72
Updated Date 11/17/2024

Earnings Date

Report Date 2024-11-07
When -
Estimate -
Actual 0.1844
Report Date 2024-11-07
When -
Estimate -
Actual 0.1844

Profitability

Profit Margin 1.54%
Operating Margin (TTM) 6.93%

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE 30.76
Forward PE 9.55
Enterprise Value 4505267403
Price to Sales(TTM) 0.46
Enterprise Value to Revenue 0.8
Enterprise Value to EBITDA 11.41
Shares Outstanding 142763008
Shares Floating 33533678
Percent Insiders 22.91
Percent Institutions 61.8
Trailing PE 30.76
Forward PE 9.55
Enterprise Value 4505267403
Price to Sales(TTM) 0.46
Enterprise Value to Revenue 0.8
Enterprise Value to EBITDA 11.41
Shares Outstanding 142763008
Shares Floating 33533678
Percent Insiders 22.91
Percent Institutions 61.8

Analyst Ratings

Rating 4.4
Target Price 22.78
Buy 2
Strong Buy 6
Hold 2
Sell -
Strong Sell -
Rating 4.4
Target Price 22.78
Buy 2
Strong Buy 6
Hold 2
Sell -
Strong Sell -

About Ardent Health Partners, Inc.

Exchange NYSE Headquaters Brentwood, TN, United States
IPO Launch date 2024-07-18 President, CEO & Director Mr. Martin J. Bonick FACHE, M.H.A.
Sector Healthcare Website https://www.ardenthealth.com
Industry Medical Care Facilities Full time employees 18400
Headquaters Brentwood, TN, United States
President, CEO & Director Mr. Martin J. Bonick FACHE, M.H.A.
Website https://www.ardenthealth.com
Website https://www.ardenthealth.com
Full time employees 18400

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​